That's essential, due to the fact that the way a protein in the body folds determines if a pharmaceutical will have the ability to bind to that protein and be reliable. To put it simply, we have to understand how these proteins fold if we want a drug to work. Historically, this has been an experimental procedure (jeff brown stock market prediction). However now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it a lot easier to develop drugs that do what they're developed to do. This was a breakthrough almost no one saw. However it's going to have extensive ramifications for curing disease. I anticipate that Alpha, Fold will be 98% precise by the end of 2021.
And, obviously, there will be plenty of investment chances in this area, too. Shifting topics It's going to be a great year for bitcoin. I'm bullish on it in 2021 (jeff brown top stock pick 2021). That said, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I would not be amazed if it pulled back perhaps considerably prior to going greater - first lady. I have actually been covering bitcoin for a long period of time now. Among the very first research study reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary suggestion, I titled my report "What's the Big Deal With Bitcoin?" That reveals you where the conversation was at the time. We were mostly educating readers. But that's not the huge question any longer. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche business. Mass, Mutual is a relied on 170-year-old organization. So consider that. In 5 years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a huge reason I'm bullish on it this year. jeff bezos. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than twenty years. These business raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I anticipate 2021 will be another record year in IPOs. There are so numerous great private companies on the verge of hitting the public markets And I have actually been dealing with a new method for you to invest even prior to these companies go public.
This opportunity has been constructing over the last few years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to discover all the details. Go right here to book your spot for complimentary.
Emma Walsh here, handling editor of the Journal. Routine Journal readers know that tech isn't our usual beat (brownstone research stock). And when it concerns tech investing, we leave it to the experts. Fortunately, we have several such specialists in our Rolodex. Our coworker Jeff Brown will recognize to our longtime readers. He is among the most accomplished tech investing specialists we understand (future report review). In truth, he had a number of triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to take an appearance at the big image and predict what's just around the corner.
That includes things like 5G networks, biotech, artificial intelligence, and far more. These trends are experiencing exponential development and creating extraordinary chances for financiers. I wish to make certain all our readers are gotten ready for what's next. And with that in mind, let me draw the image of what I see coming in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a topic I've been covering for years now. jeff brown predictions for 2021. However regardless of what lots of readers may believe, this is a pattern that's simply starting. Despite the fact that the COVID-19 pandemic interfered with supply chains last year, an impressive 250 million 5G-enabled devices were still sold.
And all of this eventually resulted in Apple postponing the release of the 5G-enabled i, Phone 12 by two months (exponential growth). Losing two months of manufacturing and sales truly affects the number of 5G devices are offered in the fiscal year. When you think about all of that, offering 250 million units is exceptional. More significantly, the delays brought on by the pandemic created a ton of pent-up need. And that need is now going to be pushed into 2021. In truth, I predict that more than 500 million 5G devices will be shipped in 2021 - what is the legacy report predicting. And that's not my only 5G prediction When I've talked about 5G in the past, I've explained its three different phases.
In Stage Two, 5G devices go on sale. 5G phones and other items begin to reach consumers. And in Stage 3, 5G services begin to be offered (artificial intelligence). That's when we start to see applications working on 5G networks. Consider things like huge multiplayer games over a cellphone. That's not possible with 4G. It will be with 5G. And my second 5G prediction for 2021 is that we will begin Phase Three by this summer season. This starts something of a virtuous cycle: Many people don't really appreciate the technology. However they will care if there are exciting applications that can only be accessed with a 5G phone.
That results in more 5G apps being developed. In fact, 5G is going to open a suite of incredible applications: self-driving cars, the Web of Things, robotic surgery, and more. All of these innovations need 5G. The investment chances moving forward will be huge. Stepping away from 5G, the next essential innovation I predict in 2021 is CRISPR genetic editing. CRISPR represents "clustered frequently interspaced short palindromic repeat." It's a mouthful. However it is among the most exciting developments in biotechnology. At a high level, CRISPR is an innovation that can modify our genetic makeup as if it were software application.
The program can crash or not function properly. CRISPR utilizes a comparable idea but with our hereditary code. "Typos" in our genome can result in illness. CRISPR can remedy these "typos." For several years, CRISPR was mainly a specific niche technology that wasn't well comprehended. And during that time, there were actually just 3 business running in this area. However things are altering. CRISPR is no longer simply theoretical. We're seeing real outcomes. We're treating illness and seeing that this innovation simply works. And as an outcome, a "2nd crop" of early-stage CRISPR companies is going public and providing amazing returns. This entire market is effectively a greenfield chance.
There's room for many business to exist in this area. future report review. And there will be more. That's my forecast for CRISPR in 2021. I predict that two or 3 more genetic modifying business will hold their IPOs. Sticking to biotechnology, we are seeing incredible things occurring at the merging of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its newest Alpha, Fold software application can precisely anticipate the folding of a protein based entirely on its amino acid sequence with 92. 4% precision. That's essential since the way a protein in the human body folds determines if a pharmaceutical will have the ability to bind to that protein and be reliable.
Historically, this has actually been an experimental procedure. Today, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it much easier to create drugs that do what they're designed to do. And here's my next prediction. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one but a number of drug treatments produced using this technology. This was one of those advancements that almost nobody noticed. However it's going to have profound implications for curing disease. And, obviously, there will be lots of investment opportunities in this space, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be amazed if it drew back maybe considerably prior to going greater. I have actually been covering bitcoin for a long time now. One of the first research reports I ever published was on bitcoin - jeff brown biotech stock pick for 2020. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on investment for anybody who followed my suggestion. But at the time of that initial recommendation, I titled my report, "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time.
But nobody is asking that question anymore. Now, we're seeing institutional money finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche business. bleeding edge. Mass, Mutual is a 150-year-old institution. So believe about that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a big reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another bonus offer forecast In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown is worth about $27. 5 million and claims the details depends on date as of February 2021, but we could not separately confirm this claim. Given Jeff Brown's past, he likely has a considerable net worth, but we can't hammer down an exact figure at this minute. Brown is best known for his sage-like capability to select winning innovation stocks. He invested more than 25 years looking into technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience offers him an exceptional viewpoint on the market. He's constantly on the hunt for brand-new opportunities, and he shares much of his finest choices in the Future Report.
That's high appreciation, but it's not ridiculously reasoned. Brown has an excellent credibility as a stock-picker, and he effectively predicted some of the most significant economic events of the previous twenty years. Although he does not appear to release his picks to the public, the service's success is a direct indication of Brown's stock-picking prowess. No one on Wall Street gets it best every time, however Jeff Brown's accurate predictions have made him legions of devoted followers. That says a lot about his capability. The Future Report is released by Brownstone Research study, a popular monetary research publisher. Brownstone Research study offers numerous research study services with a broad variety of expertises - last week.
The company is likewise associated with Bonner & Partners, another well-respected research study publisher - united states. On its website, Brownstone says its mission is to supply retail investors with professional-grade research: "For too long, the finest financial investment research study has actually not been readily available to private financiers. It has actually been typically scheduled for financial investment banks, hedge funds, personal equity, and high-net-worth clients. jeff brown biotech genome sequencing. The objective of Brownstone Research study is to make that type of exclusive research study offered to any financiers aiming to get an edge in the markets. The objective is easy to deliver special and successful investment research discovered nowhere else." -Brownstone Research website excerpt from the Jeff Brown is the creator of Brownstone Research, and he also acts as the company's Chief Financial investment Expert.
With Brown directing the ship, Brownstone Research is a powerhouse publisher with lots to provide its customers. After decades of steady success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a family name throughout most of America. If you know even a little bit about the marketplace, you know that he has a reputation as a King Midas of sorts. melania trump. Everything he touches relies on gold! Jeff is aware of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next huge job.
In reality, Brown thinks S.A.V. korean actress. could be "the greatest pattern of the 2020s, and he's not alone. Check out these quotes from other well-known S.A.V. bulls: Elon's next huge act will be weding two cutting-edge innovations: expert system and electrical cars. Musk hopes the mix will assist him establish the first fully-autonomous, self-driving cars ever. It's absolutely nothing except the vehicle market's Holy Grail. As you know, electrical cars and self-driving cars and truck stocks have been substantial this year, however the Wall Street machine has been huge on buzz without much tangible result. Regardless of a drastic increase in competitors over the previous couple of years, Brown still thinks Musk has the very best chance of putting all of it together.
tech could be the magic string that connects everything together. S.A.V. represents Shared Autonomous Automobile, and it could be the future of transportation. Basically, this technology would allow you to rent out your cars and truck as an autonomous, self-driving taxi when you're not utilizing it. You merely leave the vehicle and press a button on an app that tells the cars and truck to "sign up with the fleet." Next thing you understand, you're relaxing on your sofa while your cars and truck shuttles ride-sharers around town. Best of all, you get to keep a significant chunk of the revenues. It sounds outrageous, however it could be closed than you think.